Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Daiichi Sankyo

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050703

« Back to Dashboard

NDA 050703 describes BACTROBAN, which is a drug marketed by Glaxosmithkline and is included in three NDAs. It is available from five suppliers. Additional details are available on the BACTROBAN profile page.

The generic ingredient in BACTROBAN is mupirocin. There are twelve drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the mupirocin profile page.

Summary for 050703

Therapeutic Class:Antibacterials

Pharmacology for NDA: 050703

Mechanism of ActionRNA Synthetase Inhibitors

Medical Subject Heading (MeSH) Categories for 050703

Suppliers and Packaging for NDA: 050703

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BACTROBAN mupirocin calcium OINTMENT;NASAL 050703 NDA GlaxoSmithKline LLC 0029-1526 0029-1526-11 10 CARTON in 1 PACKAGE (0029-1526-11) > 1 TUBE in 1 CARTON (0029-1526-03) > 1 g in 1 TUBE
BACTROBAN mupirocin calcium OINTMENT;NASAL 050703 NDA Physicians Total Care, Inc. 54868-4325 54868-4325-0 10 CARTON in 1 PACKAGE (54868-4325-0) > 1 TUBE in 1 CARTON > 1 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;NASALStrengthEQ 2% BASE
Approval Date:Sep 18, 1995TE:RLD:Yes

Expired Orange Book Patents for NDA: 050703

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
GlaxosmithklineBACTROBANmupirocin calciumOINTMENT;NASAL050703-001Sep 18, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: